This Week in Business cover image

Addressing the Rising Costs of Insulin: What's the Best Way to Keep Prices Down?

This Week in Business

00:00

The Cost Difference Between Generic and Brand Name Drugs

The generic version is quite inexpensive already relative to the $300 or so a dose that was typically cited in the criticism of the brand name firms. So these companies really potentially saw their market share going down significantly, especially with that generic option coming out. That will be my conjecture.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app